Skip to main content
SpringerLink
Log in

GLP1 receptor agonists do not increase risk of thyroid cancer

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Pasternak B, et al. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study BMJ : 10 Apr 2024. Available from: URL: https://doi.org/10.1136/bmj-2023-078225

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

GLP1 receptor agonists do not increase risk of thyroid cancer. Reactions Weekly 2004, 10 (2024). https://doi.org/10.1007/s40278-024-56649-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-56649-5

Search

Navigation